tiprankstipranks
Ampio Pharmaceuticals (AMPE)
NYSE MKT:AMPE
US Market

Ampio Pharmaceuticals (AMPE) Stock Price & Analysis

508 Followers

AMPE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.70 - $8.28
Previous Close$0.81
Volume93.78K
Average Volume (3M)190.71K
Market Cap
$1.40M
Enterprise Value-$4.64M
Total Cash (Recent Filing)$6.40M
Total Debt (Recent Filing)$362.00K
Price to Earnings (P/E)>-0.1
Beta1.17
May 09, 2024
EPS EstimateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-12.05
Shares Outstanding832,021
10 Day Avg. Volume83,737
30 Day Avg. Volume190,707
Standard Deviation0.32
R-Squared0.11
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

AMPE FAQ

What was Ampio Pharmaceuticals’s price range in the past 12 months?
Ampio Pharmaceuticals lowest stock price was $0.70 and its highest was $8.28 in the past 12 months.
    What is Ampio Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Ampio Pharmaceuticals’s upcoming earnings report date?
    Ampio Pharmaceuticals’s upcoming earnings report date is May 09, 2024 which is in 42 days.
      How were Ampio Pharmaceuticals’s earnings last quarter?
      Ampio Pharmaceuticals released its earnings results on May 11, 2023. The company reported -$0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.264.
        Is Ampio Pharmaceuticals overvalued?
        According to Wall Street analysts Ampio Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Ampio Pharmaceuticals pay dividends?
          Ampio Pharmaceuticals pays a Notavailable dividend of $209.7 which represents an annual dividend yield of N/A. See more information on Ampio Pharmaceuticals dividends here
            What is Ampio Pharmaceuticals’s EPS estimate?
            Ampio Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Ampio Pharmaceuticals have?
            Ampio Pharmaceuticals has 832,021 shares outstanding.
              What happened to Ampio Pharmaceuticals’s price movement after its last earnings report?
              Ampio Pharmaceuticals reported an EPS of -$0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 23.515%.
                Which hedge fund is a major shareholder of Ampio Pharmaceuticals?
                Among the largest hedge funds holding Ampio Pharmaceuticals’s share is Sheaff Brock Investment Advisors LLC. It holds Ampio Pharmaceuticals’s shares valued at N/A.
                  ---

                  Company Description

                  Ampio Pharmaceuticals

                  Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  BioCryst
                  Bio-Path Holdings
                  Fate Therapeutics
                  Vanda
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis